|
ZNF287 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.615700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.012210E-02 |
| Normal-vs-Stage2 |
7.431400E-01 |
| Normal-vs-Stage3 |
5.985900E-04 |
| Normal-vs-Stage4 |
1.52504999999525E-05 |
| Stage1-vs-Stage2 |
4.754000E-02 |
| Stage1-vs-Stage3 |
1.608800E-01 |
| Stage1-vs-Stage4 |
5.677900E-03 |
| Stage2-vs-Stage3 |
5.744100E-03 |
| Stage2-vs-Stage4 |
3.196400E-04 |
| Stage3-vs-Stage4 |
9.010000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.789100E-04 |
| Normal-vs-AfricanAmerican |
5.148200E-02 |
| Normal-vs-Asian |
2.596300E-02 |
| Caucasian-vs-AfricanAmerican |
8.549800E-01 |
| Caucasian-vs-Asian |
6.685600E-01 |
| AfricanAmerican-vs-Asian |
9.119400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.315900E-03 |
| Normal-vs-Female |
3.104900E-03 |
| Male-vs-Female |
8.969600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.930430E-02 |
| Normal-vs-Age(41-60Yrs) |
5.562100E-03 |
| Normal-vs-Age(61-80Yrs) |
5.659900E-03 |
| Normal-vs-Age(81-100Yrs) |
3.668300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.256600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.356800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.423400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.557000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.111000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.790400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.26799999967365E-07 |
| Classical-VS-Follicular |
3.631800E-02 |
| Classical-VS-Other |
3.953600E-01 |
| Classical-VS-Normal |
2.957500E-03 |
| Tall-VS-Follicular |
2.26860000007711E-07 |
| Tall-VS-Other |
2.479800E-01 |
| Tall-VS-Normal |
3.42189999669174E-08 |
| Follicular-VS-Other |
1.989190E-01 |
| Follicular-VS-Normal |
5.501400E-01 |
| Other-VS-Normal |
6.048300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.038020E-01 |
| Normal-vs-N1 |
2.03949999999509E-05 |
| N0-vs-N1 |
3.758800E-04 |
|
|
